Zahlungsmittel Und Äquivalente Veränderung Datum
Akzo Nobel EUR 3.19B 430M 2026-06
Alcon AG USD 1.7B 350M 2026-09
AstraZeneca USD 4.89B 2.67B 2026-06
Bayer EUR 4.29B 1.44B 2026-06
Beiersdorf EUR 1.28B 82M 2026-06
DaVita Healthcare Partners USD 495.63M 173.33M 2026-09
Demant DKK 1.5B 166M 2026-06
E.ON EUR 3.44B 257M 2026-09
Essilor EUR 1.93B 1.61B 2026-06
Fresenius EUR 1.28B 780M 2026-06
Fresenius Medical Care EUR 1.1B 37.86M 2026-09
Genmab DKK 1.5B 18M 2026-06
Getinge SEK 2.05B 909M 2026-06
Givaudan CHF 603M 3M 2024-06
GlaxoSmithKline GBP 3.1B 337M 2026-06
GN Store Nord DKK 685M 121M 2026-09
GRIFOLS EUR 486M 27M 2026-09
Hikma Pharmaceutical USD 217M 19M 2025-12
Lonza CHF 719M 188M 2025-12
Merck EUR 1.96B 788M 2026-06
Novartis USD 8.87B 1.25B 2026-09
Philips EUR 2.75B 962M 2026-09
Roche Holding CHF 7.55B 579M 2025-06
RWE EUR 4.5B 2.36B 2026-09
Sanofi EUR 6.35B 806M 2026-06
SAP EUR 9.36B 1.15B 2026-09